Free Trial
NASDAQ:CTOR

Citius Oncology (CTOR) Stock Price, News & Analysis

Citius Oncology logo
$1.75 +0.12 (+7.36%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$1.72 -0.03 (-2.00%)
As of 08/22/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Citius Oncology Stock (NASDAQ:CTOR)

Key Stats

Today's Range
$1.63
$1.80
50-Day Range
$1.39
$5.32
52-Week Range
$0.55
$6.19
Volume
281,705 shs
Average Volume
468,200 shs
Market Capitalization
$137.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Consensus Rating
Hold

Company Overview

Citius Oncology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

CTOR MarketRank™: 

Citius Oncology scored higher than 27% of companies evaluated by MarketBeat, and ranked 811th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Citius Oncology has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Citius Oncology has received no research coverage in the past 90 days.

  • Read more about Citius Oncology's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Citius Oncology has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTOR.
  • Dividend Yield

    Citius Oncology does not currently pay a dividend.

  • Dividend Growth

    Citius Oncology does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CTOR.
  • News Sentiment

    Citius Oncology has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Citius Oncology this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for CTOR on MarketBeat in the last 30 days. This is a decrease of -82% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Citius Oncology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.57% of the stock of Citius Oncology is held by insiders.

  • Percentage Held by Institutions

    70.52% of the stock of Citius Oncology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Citius Oncology's insider trading history.
Receive CTOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter.

CTOR Stock News Headlines

Citius Oncology Conducts Public Offering of Stock
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Citius Oncology Beats Fiscal Q3 EPS
See More Headlines

CTOR Stock Analysis - Frequently Asked Questions

Citius Oncology's stock was trading at $1.15 at the start of the year. Since then, CTOR shares have increased by 52.2% and is now trading at $1.75.

Citius Oncology, Inc. (NASDAQ:CTOR) released its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.02.

Top institutional shareholders of Citius Oncology include Jane Street Group LLC (0.14%), Geode Capital Management LLC (0.07%), Arkadios Wealth Advisors (0.01%) and Bank of America Corp DE (0.01%).

Shares of CTOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Citius Oncology investors own include AST SpaceMobile (ASTS), Tempus AI (TEM), Advanced Micro Devices (AMD), Broadcom (AVGO), Confluent (CFLT), Genius Sports (GENI) and Intel (INTC).

Company Calendar

Last Earnings
5/14/2025
Today
8/23/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CTOR
Previous Symbol
NASDAQ:CTOR
CIK
1851484
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$3.00
Low Price Target
$3.00
Potential Upside/Downside
+71.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-51.93%
Return on Assets
-22.17%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
0.35
Quick Ratio
0.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.41 per share
Price / Book
4.27

Miscellaneous

Outstanding Shares
78,371,000
Free Float
74,789,000
Market Cap
$137.15 million
Optionable
N/A
Beta
3.00
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CTOR) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners